A carregar...
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study
BACKGROUND: Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis (RENEW) was a 5-year, phase IV study in which the safety of Mitoxantrone was monitored in a patient cohort from the United States (US). The objective of the study was to evaluate the long-term safety profile of Mitox...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3710498/ https://ncbi.nlm.nih.gov/pubmed/23841877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-13-80 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|